Michaela Liedtke

19PUBLICATIONS
100CO-AUTHORS
AutoimmunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 29, 2026
Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.

|Oct 31, 2025
Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL.

Daniela R Anderson, Radhika Gangaraju, Wafik George Sedhom

|Jul 05, 2024
A phase 1 clinical trial of NKTR-255 with CD19-22 CAR T-cell therapy for refractory B-cell acute lymphoblastic leukemia.

Hrishikesh Srinagesh, Clayton Jackson, Parveen Shiraz

|Apr 12, 2024
Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL.

Yaqi Zhao, A Douglas Laird, Kathryn G Roberts

|Jun 27, 2023
Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial.

Morie A Gertz, Adam D Cohen, Raymond L Comenzo

|Feb 13, 2023
A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma.

Barry Paul, Michaela Liedtke, Jack Khouri

Pageof 4

Frequent Collaborators

3 joint publications

Richard A Larson

3 joint publications

Efstathios Kastritis

3 joint publications

Vaishali Sanchorawala

3 joint publications

Anjali S Advani